Company intelligence / Profile preview

Omeat

Camarillo, California, United Statesomeat.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Omeat has developed a proprietary process to produce cultivated beef by growing muscle tissue from cow cells in a nutrient-rich medium derived from the plasma of healthy cows. This approach eliminates the need for fetal bovine serum, reduces animal harm, and significantly lowers environmental impact compared to conventional beef. The company’s first product will be ground beef. No clinical results are relevant as this is a food technology company; regulatory discussions with FDA/USDA are ongoing.

Therapeutic areas: Other
Modalities: Cell therapyRecombinant protein
Industry: Food & Nutrition

Partnerships

Terasaki Institute for Biomedical Innovation (founding partner/spinout source)

Beyond the preview

Go deeper on Omeat.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omeat.

Explore the full profile